IgG4相关性硬化性胆管炎误诊为肝门部胆管癌原因分析OACSTPCD
Cause of Misdiagnosis of IgG4-related Sclerosing Cholangitis as Hilar Cholangiocarcinoma
目的 探讨IgG4 相关性硬化性胆管炎(IgG4-SC)的临床特点、分型、临床表现、诊治要点及误诊为肝门部胆管癌(HCCA)的原因,并且总结防范误诊措施.方法 回顾分析2021 年3 月—2022 年6 月收治的IgG4-SC误诊HCCA的2 例病例资料.结果 2 例均为中老年男性,分别以皮肤、巩膜黄染伴皮肤瘙痒,上腹痛、食欲不振、黄疸为主要表现就诊,体质量减轻,查血肝功能、部分肿瘤标志物异常,影像学检查示肝门部梗阻征象,提示占位性病变,初步诊断为HCCA,行手术治疗.手术病理检查均未发现肿瘤细胞,均见胆管壁大量浆细胞和淋巴细胞浸润,完善IgG4 检查均升高(分别为14.3 g/L、141.6 g/L),修正诊断为IgG4-SC.确诊后均予甲泼尼龙静脉冲击治疗,待黄疸症状消失,复查肝功能基本恢复正常后出院,院外均予泼尼松片口服并逐渐减量至维持剂量长期维持治疗,随访至今均无复发,血清IgG4 均处于正常水平.结论 IgG4-SC临床少见,临床表现与HCCA有相似之处,鉴别诊断较为困难,容易误诊;临床医生应加强对IgG4-SC临床特点、表现、诊断及鉴别诊断相关知识的学习,扩展诊断思维,全面分析病情,及时行血清IgG4 检测、糖皮质激素试验性治疗,必要时可行组织病理学检查,以减少临床误诊误治的发生.
Objective To investigate the clinical characteristics,types,clinical manifestations,diagnosis and treat-ment of IGG4-related sclerosing cholangitis(IgG4-SC)and the causes of misdiagnosis as hilar cholangiocarcinoma(HCCA),and to summarize the prevention measures of misdiagnosis.Methods The data of 2 patients with IgG4-SC misdiagnosed with HCCA admitted from March 2021 to June 2022 were retrospectively analyzed.Results The two patients were middle-aged and elderly males.The main manifestations were yellow skin and sclera with skin pruritus,epigastrica,loss of appetite and jaundice.The body weight was reduced,blood and liver function and some tumor markers were abnormal,and imaging exami-nations showed signs of hilar obstruction,suggesting space occupying lesions.The preliminary diagnosis was HCCA,and sur-gery was performed.No tumor cells were found in the post-surgical pathological examination,and a large number of plasma cells and lymphocytes were found in the bile duct wall in both patients.Therefore,the improved IgG4 examination showed ele-vated levels(14.3 g/L and 141.6 g/L,respectively),and then the revised diagnosis was IgG4-SC.After diagnosis,all pa-tients were treated with Methylprednisolone intravenous pulse therapy.After jaundice symptoms disappeared and liver function basically returned to normal after review,they were discharged from the hospital.All patients outside the hospital were given prednisone tablets orally,which were gradually reduced to a maintenance dose for long-term maintenance treatment.No recur-rence was reported since follow-up,and serum IgG4 levels remained normal.Conclusion IgG4-SC is rare in clinical prac-tice,and its clinical manifestations are similar to HCCA;therefore,it is difficult to differentiate IgG4-SC and more likely to lead to misdiagnosis.Clinicians should strengthen the understanding of the clinical characteristics,manifestations,diagnosis and differential diagnosis of IgG4-SC,expand their diagnostic thinking,comprehensively analyze the condition,and promptly conduct serum IgG4 detection,experimental treatment with Glucocorticoid,and histopathological examination if necessary,so as to reduce the occurrence of clinical misdiagnosis and misdiagnosis.
杜海宽;赵雪琦
066000 河北 秦皇岛,北京大学第三医院秦皇岛医院普外科
临床医学
IgG4相关性硬化性胆管炎误诊胆管肿瘤IgG4糖皮质激素鉴别诊断病理学检查
IgG4-related sclerosing cholangitisMisdiagnosisBile duct tumorIgG4GlucocorticoidDifferential diagnosisPathological examination
《临床误诊误治》 2024 (007)
12-15 / 4
秦皇岛市科技计划自筹项目(201902A138)
评论